Skip to Content

Cerevel Therapeutics

CERE

Buy $CERE at eToro
Rank 2192
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 131 DARTMOUTH STREET, SUITE 502, BOSTON, MA, US

Cerevel Therapeutics - Key figures

Market cap 3.92 Billion
Revenue No information
Profit No information
P/E Ratio No information
P/s Ratio -
Buy $CERE at eToro

Cerevel Therapeutics - Description

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various therapies for neuroscientific diseases.

The company is headquartered in Cambridge, Massachusetts.